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INTRODUCTION
THE SARCOPLASMIC RETICULUM (SR) is an intracellularorganelle that controls the contractile state of muscle by
regulating the Ca2+ concentration in the cytosol. By hydrolysis
of ATP, the SR actively accumulates Ca2+ into its lumen, which
leads to muscle relaxation. Depolarization of the T-tubule
results in release of Ca2+ from the SR, which induces muscle
contraction. In skeletal muscle, there appears to be a mechani-
cal coupling between the dihydropyridine receptor (DHPR)
found in the T-tubule membrane and the CRC or ryanodine re-
ceptor (RyR) found at the terminal end of the SR (30). In
cardiac muscle, Ca2+ enters the cell during the action potential
through the DHPR, and initiates Ca2+ release from the SR via
a mechanism known as Ca2+-induced Ca2+ release (7).
The CRC from both cardiac and skeletal muscle SR are
rich in thiol groups, and are strongly regulated by thiol
reagents. Oxidation of thiols results in increased Ca2+ release
rates from SR vesicles, increased open probability of the
reconstituted CRC, and increased high affinity ryanodine
binding to the SR, while reduction of the disulfide(s) formed
results in decreased activity (1, 36, 40, 43). There are also a
large number of non-thiol physiologically and pharmacologi-
cally diverse reagents known to either activate or inhibit the
skeletal muscle ryanodine receptor (RyR1) and/or the cardiac
muscle ryanodine receptor (RyR2). Local anesthetics such as
tetracaine and procaine (42) inhibit both skeletal and cardiac
muscle SR, while the polyunsaturated fatty acid docosa-
hexaenoic acid (DHA) inhibits RyR2 (13). Caffeine activates
both RyR1 and RyR2 at millimolar concentrations and
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The Ca2+ release channel (CRC) from sarcoplasmic reticulum (SR) is rich in thiol groups, and their oxidation/-
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the thiol–disulfide balance within CRC by transiently exchanging electrons with the Ca2+ release protein.
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sensitizes the receptor to activation at low Ca2+ concentrations
(23). Both anthraquinones such as doxorubicin and mitoxan-
throne, and naphthoquinones such as 1,4-naphthoquinone and
menadione appear to activate the Ca2+ release mechanism of
SR by oxidizing thiols on the ryanodine receptor (1, 11).
Previous studies have demonstrated that non-thiol regula-
tors of L-type Ca2+ channels and Na+ channels exchange
electrons with dye-free radicals. Antagonists of the DHPR,
such as diltiazem, verapamil, and felodipine all act as electron
donors to dye-free radicals. When a dihydropyridine antago-
nist was chemically modified to generate an agonist, both
drugs bound to the same site on the DHPR (12). However, the
L-type Ca2+ channel agonist now acted as an electron acceptor
(20). A correlation between electron donor/acceptor proper-
ties of a drug, as measured with dye-free radicals, and its
ability to act as an inhibitor/activator of L-type Ca2+ channels
suggests that modulators of the Ca2+ release mechanism might
also show similar electron donor/acceptor properties.
In this paper we describe a method for measuring the redox
activity of CRC regulators by their reactions with free radi-
cals. We refer to this as a compound’s weak redox activity. In
spite of their diverse structures, many activators acted as elec-
tron acceptors, while many channel inhibitors acted as elec-
tron donors toward free radicals. Moreover, electron
acceptors, which activate the CRC, shift the redox potential
of hyperreactive thiols to more negative values and decrease
the number of reactive thiols on the RyR1, which is consis-
tent with an oxidation of these thiols. In contrast, electron
donors, which inhibit the CRC, shift the redox potential to
more positive values and increase the number of reactive
thiols on RyR1, which indicates that endogenous disulfides
have been reduced to thiols that are now free to react with the
fluorescent maleimide CPM. These observations strongly
suggest that weak redox reactions mediate the effects of non-
thiol channel activators and inhibitors.
MATERIALS AND METHODS
Preparation of SR vesicles and RyR1s
Skeletal muscle SR was isolated from back and leg muscles
of New Zealand White rabbits by the method of MacLennan
with small modifications (16). Fifty micromolar dithiothreitol
and 0.2 g/ml leupeptin were added to all buffers except for the
final SR suspension buffer. Samples were stored in liquid N2.
Heavy SR vesicles (HSR) derived from the terminal cister-
nae region were purified on a discontinuous sucrose gradient
as previously described (25). Approximately 6 mg of skeletal
muscle HSR was solubilized in 0.4% CHAPS and applied to a
Sephacryl S300 HR gel filtration column, and fractions were
eluted as previously described (38).The isolated RyR1, which
was eluted in the void volume of the column, was high in 3H-
ryanodine binding. The protein concentration was determined
using the amido black protein assay (28).
[3H]-Ryanodine binding experiments
Equilibrium binding of [3H]-ryanodine was carried out
according to the method of Pessah et al. (23) . SR vesicles
(0.5 mg/ml) were incubated with various concentrations of
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reagents in 0.2 ml of standard ryanodine binding buffer con-
taining 250 mM KCl, 15 mM NaCl, 20 mM Pipes, 100 M
CaCl2, 50 M EGTA, 1 nM [
3H]-ryanodine, 14 nM ryanodine,
pH 7.1, at 37°C for 3 h. Each assay was performed in dupli-
cate and each was repeated at least three times. The binding
reaction was quenched by rapid filtration through Whatman
GF/B filters mounted on a 24-well Brandel Cell Harvester
(Gaithersburg, MD).
The initial rate of [3H]-ryanodine binding was determined
from time-dependent measurements at 4, 8, 12, and 16 min at
37°C. SR vesicles (0.5 mg/ml) were incubated in 0.2 ml of
binding buffer containing 3 nM [3H]-ryanodine. The initial
binding rate was calculated from a linear regression fit of
four time-dependent measurements of bound ryanodine. The
derived slope is the initial rate of ryanodine binding. Subtrac-
tion of nonspecific binding does not affect the rate of bind-
ing, and therefore no subtraction was made. In redox titrations,
the initial rate of ryanodine binding was measured vs. the
solution redox potential, as previously described (40). The
solution redox potential is defined as Esol = –240 mV + 2.3
(RT/nF) log10 [GSSG]/[GSH]
2, where R is the gas constant
(8.31 deg-1mol-1), T is the absolute temperature (K), n is the
number of electrons transferred (n = 2), and F is Faraday’s
constant (96,406 J/V) (27). The binding reaction was
quenched by rapid filtration through Whatman GF/B filters
mounted on a 48-well Brandel Cell Harvester. Filters were
rinsed three times with a wash buffer containing 50 M Ca2+.
They were then put into scintillation vials, filled with scintil-
lation fluid, shaken overnight, and counted the following day.
All equilibrium ryanodine binding assays and measurements
of the rate of ryanodine binding were repeated at least three
times and are reported as the mean value ± S.D.
Measurement of redox properties of 
channel modulators
Methods for determination of redox properties of biologi-
cally active compounds by their reaction with free radicals in
de-aerated solutions has previously been described (19). In
the presence of O2, the electron donor/acceptor activity of
redox active compounds was measured as described in Fig. 1.
Visible light illuminates a dye (methylene blue)-containing
solution, which leads to the production of dye anion (Dye–)
and dye cation (Dye+) radicals. Under normal conditions,
the dye anion and cation radicals rapidly recombine. How-
ever, in the presence of an electron donor, its electrons are
passed to the dye cation radicals, decreasing their concentra-
tion, and increasing the lifetime of the dye anion radical.
When two anion radicals combine, the dye bleaches. In the
presence of O2, the dye anion radicals and the bleached dye
reduce O2 to form superoxide (O2
–). The superoxide
produced is detected with an optical probe such as NBD-Cl
(4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole) (22) or XTT 
(2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide) (33). The spectral changes were quantified by
measuring the increased absorbance at 470 nm as a function
of time using a HP8452A diode array spectrophotometer
(Hewlett-Packard/Agilent Technology, Santa Clara, CA) or
an Ocean Optics (Dunedin, FL) USB2000 UV/Visible spec-
trophotometer.
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In the presence of a drug that accepts electrons from dye
anion radicals, dye photo bleaching decreases and the
production of superoxide also decreases. For better sensitiv-
ity, the initial concentration of dye anion radicals was in-
creased in the presence of an auxiliary electron donor such as
NADH or EDTA. The difference between the probe’s ab-
sorbance at 470 nm as well as the bleaching of the dye in the
presence and absence of the compound are taken as a mea-
sure of electron-acceptor activity of the compound.
In order to test whether a compound is an electron donor,
the auxiliary donor was replaced with the reagent to be tested.
If the compound tested is an electron donor, dye photo
bleaching increases, as does the production of superoxide,
which is detected with NBD-Cl or XTT.
These assays monitor the ability of drugs to donate electrons
to dye cation radicals, or to accept electrons from dye anion rad-
icals. The redox potential of dye cation radicals are very posi-
tive, while the redox potential of the dye anion radicals are very
negative. The cation radicals readily accept electrons from a
“weak electron donor,” while the anion radicals readily donates
electrons to a “weak electron acceptor.” This represents a sensi-
tive assay to measure the “weak redox” properties of drugs.
All measurements of the electron donor/acceptor properties of
different modulators of the CRC were repeated at least three
times. The mean ± the standard deviations are shown in Figs. 2–5.
Kinetics of CPM labeling
SR was labeled with 7-diethylamino-3-(4’-maleimidyl-
phenyl)-4-methylcoumarin (CPM) using the method of Liu
et al. (15), as modified by Xia et al. (40). SR at 0.1 mg/ml
was incubated in standard ryanodine binding buffer (without
ryanodine) containing 20 M Ca2+ with various concentra-
tions of caffeine, and/or tetracaine at room temperature with
rigorous stirring. The reaction was initiated by addition of
80 nM CPM, and its fluorescence (excitation = 397 nm, emission
= 465 nm) was monitored over a 3-min time scale using a PTI
(Birmingham, NJ) QuantaMaster Model QM-4/2005 spectro-
fluorometer. Control experiments showed that neither tetra-
caine nor caffeine change the fluorescence of CPM, subse-
quent to its reaction with SR thiols.
Measurement of thiol content of RyR1
The isolated RyR1 (1.0 g/ml) was suspended in a buffer
containing 250 mM KCl, 15 mM NaCl, 20 mM Pipes, pH 7.1,
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with different concentrations of CRC modulators for 10 min
at room temperature. The thiol-specific fluorescent probe
CPM (10 M) was added and incubated with the RyR1 for
30 min. The final CPM fluorescence was measured at an
excitation wavelength of 397 nm and an emission wavelength
of 465 nm. Calibrations of the CPM fluorescence vs. [GSH]
were linear over the range of 0–5 M GSH. The calculated
number of thiols is normalized to the number of moles of
RyR1. Measurements were repeated four times, with the
mean ± SD shown. 
Chemicals
Ryanodine was purchased from Calbiochem (San Diego,
CA). [3H]-ryanodine was purchased from Perkin Elmer Life
Sciences (Boston, MA). Hepes and Pipes were purchase from
Research Organics (Cincinnati, OH). Mitoxantrone diacetate
was a gift from the Drug Synthesis and Chemistry Branch,
Division of Cancer Treatment, National Cancer Institute. CPM
was purchased from Invitrogen Molecular Probes (Eugene,
OR). All other reagents were purchased from Sigma–Aldrich
(St. Louis, MO).
RESULTS
Caffeine activates the SR Ca2+ release mechanism and in-
creases ryanodine binding at millimolar concentrations (23).
As shown in Fig. 2, caffeine acts as an electron acceptor at
low millimolar concentrations. Illumination of a methylene
blue (MB) solution with NADH results in fast MB bleaching
and superoxide production in the control sample (without caf-
feine). Caffeine dose-dependently decreased both dye photo
bleaching and superoxide production, manifesting its electron
acceptor properties. In the absence of light, no MB bleaching
is observed.
Anthraquinones, such as doxorubicin and mitoxanthrone,
are widely used antineoplastic agents. However, their useful-
ness as anti-tumor agents is limited by their cardiotoxicity.
Previous studies have shown that both doxorubicin and
mitoxanthrone are potent stimulators of the CRC, and that
Ca2+ release induced by these agents is reversed by subse-
quent addition of the reducing agent dithiothreitol (1). This
suggests that both of these reagents induce Ca2+ release by
promoting the oxidized state of thiols associated with the
FIG. 1. Scheme illustrating the pro-
tocol for measuring the electron ac-
ceptor/donor properties of reagents.
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CRC. This hypothesis is supported by the data presented in
Fig. 3. Doxorubicin (40 M) and mitoxanthrone (10 M)
decrease the bleaching of MB, and simultaneously decrease
NBD-Cl reduction by superoxide. Both of these anthraquinones
act as electron acceptors.
In vivo, the cytoplasm of the cell is maintained in a reduc-
ing environment by a large excess of reduced glutathione
(GSH) over oxidized glutathione (GSSG). A previous study
has shown that GSSG increases ryanodine binding and acti-
vates the CRC, while GSH decreases ryanodine binding and
inactivates the CRC (43). Figure 4A shows that superoxide
production (A470) and dye bleaching (A663) promoted by the
auxiliary electron donor NADH in the control samples are at-
612 MARINOV ET AL.
tenuated by the thiol oxidizing agents cystine, GSSG, and
diamide. It is likely that all of these agents act as electron
acceptors, accepting electrons from MB anion radicals, and
hence decreasing dye photo bleaching and the production of
superoxide. At equal concentrations (1 mM), cystine was a
more potent electron acceptor than GSSG, while diamide
showed comparable electron acceptor activity with cystine at
a much lower concentration. Measurements of the electron
donor properties of cysteine and GSH (Fig. 4B) were carried
out in the absence of the auxiliary electron donor NADH.
Photo bleaching of methylene blue is more rapid and com-
plete in the presence of cysteine than it is with equal concen-
tration of GSH. Cysteine is a better electron donor than is
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FIG. 3. Electron acceptor activity of the an-
thraquinones doxorubicin and mitoxan-
throne. Samples were continuously illumi-
nated, as described in Fig. 2, in a buffer
containing 1.0 mM Tris, pH 7.3, 50 M
NADH, 10 M methylene blue, 100 M
NBD-Cl. Photo bleaching of methylene blue
(open symbols), and reduction of NBD-Cl
(filled symbols) are shown as a function of
illumination time. Control traces (, ), with
40 M doxorubicin (, ), or 10 M mitox-
anthrone (, ). The data shown are the mean
± S.D. (n = 3).
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FIG. 2. Caffeine is an electron acceptor. A
mixture of 80% DMSO and 20% buffer
(10 mM Tris, pH 7.4), containing 200 M
EDTA (as an electron donor), 10 M methyl-
ene blue, 100 M NBD-Cl. Photo bleaching of
methylene blue was followed as a decrease in
the absorption at 663 nm (open symbols), and
the reduction of NBD-Cl was simultaneously
recorded as an increase in the absorbance
at 470 nm (filled symbols) as a function
of time of illumination using a projector
(3.0 mW/cm2) with light passing through a
band pass filter (600–700 nm) in an aerobic
environment. Control traces (,  ), with
1.0 mM caffeine (, ), and 2.0 mM caffeine
(, ) are superimposed. The solid lines
shown are time-dependent exponential fits to
the data. The data shown are the mean ± S.D.
(n = 3).
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FIG. 4. Thiol oxidizing agents are elec-
tron acceptors and thiol reducing agents
are donors of electrons. (A) Samples
were continuously illuminated, as described
in Fig. 2, in a buffer containing 1.0 mM Tris,
pH 7.3, 50 M NADH, 10 M methylene
blue, 100 M XTT. Photo bleaching of
methylene blue (open symbols), and reduc-
tion of XTT (filled symbols) are shown as a
function of illumination time. Control
traces (, ), with 1.0 mM GSSG (, ),
1.0 mM cystine (, ), or 50 M diamide
(, ). (B) Samples were illuminated in a
mixture of 80% DMSO and 20% buffer (1.0
mM Tris, pH 7.3), containing 10 M meth-
ylene blue. Control traces  (), with 1.0 mM
GSH (), or 1.0 mM cysteine (). The data
shown are the mean ± S.D. (n = 3).
GSH, in spite of the fact that they have similar redox poten-
tials. In the dark, both cysteine and GSH are able to reduce
NBD-Cl and XTT but not MB. Therefore, measurements in
Fig. 4B were carried out in the absence of either XTT or
NBD-Cl.
Some CRC inhibitors are compounds that block voltage-
dependent Na+ channels, like local anesthetics. It has previ-
ously been shown that local anesthetics reversibly inhibit sin-
gle channel activity of the isolated RyR1, and Ca2+ fluxes
across SR vesicles (42). Inhibition of CRC activity induced
by tetracaine is not voltage dependent. Unlike GSH and cys-
teine, the local anesthetics tetracaine and procaine do not
contain sulfhydryl groups. In the control, slow MB bleaching
was caused by a low concentration of Tris (200 M) with
marginal donor activity. Tetracaine and procaine (50 M)
both increased dye photo bleaching, manifesting their elec-
tron donor activity. However, tetracaine was a better electron
donor than procaine (Fig. 5). A Na+ channel blocker with a
different structure, the polyunsaturated fatty acid DHA, also
behaved as an electron donor promoting dye bleaching but at
a higher concentration (400 M). Tetracaine and procaine do
not bleach methylene blue in the absence of light.
Polyunsaturated fatty acids appear to protect myocytes
from the consequences of ischemia. It has been shown that
docosahexaenoic acid (DHA) reduced the intensity of Ca2+
sparks in single rat myocytes and inhibits single channel ac-
tivity of the cardiac CRC at micromolar concentrations (13).
In Fig. 5, it is shown that, in a similar concentration range,
DHA increases the rate and amount of methylene blue photo
bleaching. DHA acts as an electron donor and inhibits ryan-
odine binding to SR (Fig. 6). The IC50 for DHA inhibition of
the skeletal muscle ryanodine receptor was ~100 M, which
was approximately twice as high as the corresponding value
reported with the cardiac receptor (13). No significant
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electron acceptor properties were observed for the channel
inhibitors tested (data not shown).
Caffeine is one of the earliest known activators of Ca2+
release from SR (38). At millimolar concentrations, caffeine
activates ryanodine receptor binding (23), and single channel
activity (24). Figure 2 shows that caffeine acts as an electron
acceptor, while in Fig. 5 it is shown that the local anesthetics
tetracaine and procaine, which inhibit the CRC, are electron
donors. If there is a common site or sites in which electrons
are exchanged within the RyR1, when these reagents modify
channel function, then one might expect that caffeine and
tetracaine should competitively interact with one another. In
Fig. 7A, we examine the ability of caffeine to activate the ini-
614 MARINOV ET AL.
tial rate of ryanodine binding in the absence and presence of
15 M and 50 M tetracaine. The data were fit to the
Michaelis–Menton equation. As seen in Fig. 7A, in the pres-
ence of increasing concentrations of tetracaine, higher con-
centrations of caffeine are required to obtain the same initial
rate of ryanodine binding. Tetracaine antagonizes caffeine’s
activating effects. In Fig. 7B, the data derived from Fig. 7A
are replotted as a double reciprocal plot. vo represents the rate
of ryanodine binding in the absence of caffeine, (v – vo)
denotes the amount of activation of the rate of ryanodine
binding induced by caffeine. The fit lines intersect the ordi-
nate at a single point, indicating that tetracaine and caffeine
competitively interact in modulating the function of the
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FIG. 6. Docosahexaenoic acid inhibits ryan-
odine binding to SR. Equilibrium [3H]-ryan-
odine binding was measured as described in Ma-
terials and Methods. SR vesicles (0.5 mg/ml)
were incubated in buffer containing 250 mM
KCl, 15 mM NaCl, 20 mM Pipes, 100 M CaCl2,
50 M EGTA, 1 nM [3H]-ryanodine, 14 nM
ryanodine, pH 7.1, as a function of [DHA] at
37°C for 3 h. Each assay was performed in
duplicate and each was repeated three times. The
data shown are the mean ± S.D. (n = 3).
0.0
-0.3
-0.2
-0.6
-0.4
0 2 4 6 8 10 12
Illumination time (sec)
M
et
hy
le
ne
 b
lu
e
 p
ho
to
bl
ea
ch
in
g 
(A
66
3 
n
m
)
-0.1
-0.7
-0.5
14 16
FIG. 5. Local anesthetics and docosahexa-
enoic acid are electron donors. Samples
were illuminated in a mixture of 80% DMSO
and 20% buffer (1.0 mM Tris, pH 7.3), contain-
ing 10 M methylene blue and 100 M NBD-
Cl. Control traces (), with 400 M DHA (),
50 M procaine (), or 50 M tetracaine ().
The data shown are the mean ± S.D. (n = 3).
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RyR1. In a similar manner, doxorubicin, an activator of
RyR1(1), and an electron acceptor (Fig. 3) also competitively
interacts with tetracaine (not shown). Although the structures
of doxorubicin and caffeine are very different from that of the
local anesthetic tetracaine, and it is unlikely that they bind to
the same site on the RyR, they competitively interact. The
electron donor, tetracaine, and the electron acceptors, caf-
feine and doxorubicin, appear to functionally compete by
donating electrons to or accepting electrons from a common
site or sites.
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Using the maleimide CPM, which fluoresces when it reacts
with thiols, it has been demonstrated that there exists a class
of hyperreactive thiols on RyR1 which are exposed when the
Ca2+ release channel is in the closed configuration (15). The
rate of CPM fluorescence increases ~10-fold in the closed
configuration of the CRC. Seven thiols per monomeric
receptor unit have recently been identified as hyperreactive
(37), one of which (cys 3635) had previously been identified
as the binding site for NO and calmodulin (32). It has
previously been shown that these hyperreactive thiols have a
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FIG. 7. Tetracaine competitively inhibits
caffeine activation of ryanodine binding.
The initial rate of ryanodine binding was
measured as in Materials and Methods. (A)
The initial rate of ryanodine binding is plot-
ted versus the caffeine concentration in the
absence () or presence of 15 M tetracaine
() or 50 M tetracaine (). (B) The same
data is displayed in a double reciprocal plot.
vo, the initial rate of ryanodine binding in the
absence of caffeine; v, the initial rate of ryan-
odine binding in the presence of the indi-
cated concentration of caffeine. All measure-
ments were made at 37°C. The data shown
are the mean ± S.D. (n = 3).
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well-defined redox potential which is sensitive to the open
versus closed state of the CRC (40).
Not only do caffeine and tetracaine competitively interact
to activate and inhibit the rate of ryanodine binding (Fig. 7),
the development of CPM fluorescence is also oppositely af-
fected by caffeine and tetracaine (Fig. 8). In the presence of a
[Ca2+] optimal for channel activity (50 M), the rate of CPM
fluorescence is relatively slow (control; trace a). The rate of
CPM fluorescence is increased at a lower [Ca2+] (20 M;
trace b). Caffeine (2 mM; trace c) slows down the kinetics of
CPM fluorescence. In the presence of 20 M Ca2+ + 2 mM
caffeine, addition of 5 M tetracaine (trace d), reverses the
effect of caffeine, and increases the rate of alkylation of hy-
perreactive thiols by CPM. The effects of the CRC activators
Ca2+ and caffeine, and the inhibitor tetracaine oppositely af-
fect the thiol status within the CRC.
This observation is supported by the effects of channel reg-
ulators on the redox potential of hyperreactive thiols on the
CRC. Redox titrations, using GSH and GSSG to set the solu-
tion redox potential, have been used to measure the redox po-
tential of hyperreactive thiols associated with the CRC (40).
As the redox potential becomes more positive (more oxidiz-
ing), the rate of ryanodine binding increases. As the potential
becomes more negative (more reducing), the rate of ryanodine
binding decreases to a minimum value (dB/dtmin = 0.002
pmol/mg/min). The redox potential of the receptor corre-
sponds to the point at which half of the reactive thiols are oxi-
dized and half are reduced. This corresponds to the point at
which the initial rate of ryanodine binding is half maximal.
Figure 9A shows the rate of ryanodine binding to an SR vesi-
cle suspension. In the control titration (20 M Ca2+), reactive
thiols have a redox potential of –160.3 ± 3.2 mV. Caffeine
(2 mM) shifts the curve to the left, causing the redox potential
to become more negative (–197.8 ± 5.8 mV). In contrast, in
the presence of a CRC inhibitor, 25 M tetracaine, the redox
potential shifts to a more positive value (–147.7 ± 2.8 mV).
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Tetracaine has shifted the redox balance of SR thiols to a more
reduced state. As observed in Fig. 8, in the presence of 2 mM
caffeine + 5 M tetracaine, CPM binding to hyperreactive thiols
is similar to control kinetics (compare Fig. 8, traces b and d).
In a similar manner, the redox titration in the presence of
2 mM caffeine (–197.8 ± 5.8 mV) shifts toward the control
value (–160.3 ± 3.2 mV) in the presence of 2 mM caffeine +
5 M tetracaine (–171.3 ± 2.1 mV). The effect of caffeine (an
electron acceptor) is to shift the redox state of hyperreactive
thiols to a more oxidized state, while the effect of tetracaine (an
electron donor) is to shift these thiols to a more reduced state.
The ability of caffeine to shift the thiol/disulfide balance
toward a more oxidized state, and the ability of tetracaine to
shift reactive thiols toward a more reduced state is also dem-
onstrated by measuring the number of free thiols in the iso-
lated RyR1 (Fig. 9B). For this purpose, a large excess of CPM
was incubated with the isolated RyR for 30 min to ensure that
all accessible SH groups on the RyR had reacted with CPM.
The number of accessible thiols in the absence of added chan-
nel modulators (46.9 ± 1.8/mole of RyR1) was observed with
three different preparations of the isolated RyR1. Caffeine
decreased dose-dependently the number of CPM labeled thi-
ols to 35.1 ± 5.1/mole of RyR1 at 3 mM (filled circles in Fig.
9B). This corresponds to a loss of 11.8 ± 5.4 thiols/mole of
RyR1. In the presence of tetracaine, the number of CPM-la-
beled thiols increase up to 66.9 ± 3.1/mole of RyR1 at 3 mM
tetracaine (open circles). This corresponds to an increase of
20.0 ± 3.6 thiols/mole of RyR1. The skeletal muscle ryan-
odine receptor contains 100 cysteines/RyR1 (34) plus 1 cys-
teine per FK506 binding protein (14). The fractional change
in the number of reactive thiols upon addition of caffeine and
tetracaine corresponds to 11.8% and 20%. respectively. Treat-
ment of the isolated RyR1 with 2 mM caffeine + 25 M or
50 M tetracaine restores the number of CPM accessible thi-
ols/mole of RyR1 to 46.5 ± 1.8, and 48.7 ± 2.1, respectively
(triangles).
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FIG. 8. Caffeine and tetracaine modify reactivity
of hyperreactive thiols oppositely. SR vesicles
(0.1 mg/ml) were treated with increasing concentra-
tions of caffeine and tetracaine in standard ryan-
odine binding buffer containing: (a) 50 M Ca2+;
(b) 20 M Ca2+free (40 M Ca
2+ + 20 M EGTA);
(c) 20 M Ca2+ free + 2 mM caffeine; (d) 20 M Ca
2+
+ 2 mM caffeine + 5 M tetracaine. The reaction
was initiated by the addition of 80 nM CPM. CPM
fluorescence (excitation at 397 nm, emission at 465
nm) is expressed in counts per second (cps). This
experiment was repeated three times with very sim-
ilar results.
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DISCUSSION
The main finding in this work is the discovery of the weak
redox properties of regulators of the calcium release channel
from SR. Channel activators were shown to be electron ac-
ceptors while channel inhibitors were shown to be electron
donors. The weak redox properties of these CRC regulators
appear to control the reactivity of critical thiols, their redox
potential, and the thiol/disulfide balance within the ryanodine
receptor protein. These observations suggest that the weak
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redox activity of CRC modulators underlie the molecular
mechanisms of their action.
The SR Ca2+ release mechanism has previously been
shown to be sensitive to thiol oxidizing and reducing agents.
Addition of physiologically relevant thiol oxidizing agents
(H2O2, HOCl, GSSG and superoxide) activate the CRC
(8–10, 41), while addition of thiol reducing agents (GSH,
DTT, and -mercaptoethanol) inhibit the CRC (43). The list
of pharmacologically interesting thiol oxidizing agents that
increase the activity of the CRC is large (2, 21, 36). Moreover,
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FIG. 9. Caffeine and tetracaine alter the
redox potential and the number of reac-
tive thiols on the RyR1. (A) The initial
rate of ryanodine binding was measured as
a function of solution redox potential, as
described in Materials and Methods over a
16 min time period. The control
experiment was carried out with 20 M
Ca2+ [ERyR = –160.3 ± 3.2 mV] (	), or with
20 M Ca2+ + 2 mM caffeine [ERyR =
–197.8 ± 5.8 mV] (), with 20 M Ca2+ +
25 M tetracaine [ERyR = –147.7 ± 2.8
mV] (), or with 20 M Ca2+ + 2 mM caf-
feine + 5 M tetracaine [ERyR = –171.3 ±
2.1 mV] (). All assays were carried out at
37°C, in ryanodine binding buffer contain-
ing 3 nM 3H-ryanodine at an SR concentra-
tion of 0.1 mg/ml. The redox potential
[ERyR = mean ± S.D.] was derived from at
least three experiments. (B) Following ex-
posure of the isolated RyR1 (1.0 g/ml) in
a buffer containing 250 mM KCl, 15 mM
NaCl, 20 mM Pipes, pH 7.0, to increasing
concentrations of caffeine (), or tetra-
caine (), or caffeine + tetracaine () for
10 min at room temperature, samples were
exposed to 10 M CPM for 30 min, and
the fluorescence was measured (excitation
at 397nm, emission at 465 nm). CPM
fluorescence was calibrated with known
concentrations of GSH (0–5 M) and the
signal was normalized to the [RyR] de-
rived from the amido black assay (28). The
data shown are the mean ± S.D. (n = 4).
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the activation of the RyR by NO, S-nitrosocysteine, and HNO
all are due to their interaction with endogenous thiols associ-
ated with the RyR (4, 6, 31).
It has been shown that the SR Ca2+ release mechanism con-
tains hyperreactive thiols that are readily labeled with the flu-
orescent maleimide CPM when the channel is in a closed
state, but are not accessible when channel activators are
added (15). Moreover, these thiols have a well-defined redox
potential which is sensitive to the open versus closed state of
the CRC (40). Addition of a non-thiol Ca2+ release channel
activator shifts the redox potential of these thiols to more
negative values, which favors the oxidation of these thiols,
and significantly decreases the number of CPM accessible
thiols. In contrast, addition of a non-thiol channel inhibitor,
shifts the redox potential of these thiols to more positive val-
ues, which favors the reduced state of these thiols, and signif-
icantly increases the number of CPM reactive thiols (Fig. 9).
The effects of these non-thiol activators and inhibitors are re-
versible. It has been proposed that during oxidative stress,
when the cellular redox potential becomes more positive,
these thiols oxidize, and as a result the cellular Ca2+ concen-
tration increases (40). The reason for the shift in the redox po-
tential of hyperreactive thiols induced by addition of channel
activators or inhibitors was believed to be driven by the con-
formational state of the RyR. In this paper an alternative
model is presented.
Using a model system for assaying the electron donor ver-
sus electron acceptor properties of Ca2+ channel modulators,
we observe for the first time that many Ca2+ channel activa-
tors were weak electron acceptors, and that many Ca2+ chan-
nel inhibitors tested were weak electron donors. The donation
of electrons favors the reduced state of endogenous protein
thiols. The withdrawal of electrons by the addition of an elec-
tron acceptor favors the oxidized state of these thiols to the
disulfide form. Given that channel gating is a dynamic re-
versible rapid process, it is likely that a shift in the electron
density within the protein, induced by addition of a channel
modulator, may be responsible for the action of these channel
activators (electron acceptors) or channel inhibitors (electron
donors). All of the above observations suggest that the mech-
anism underlying release of Ca2+ via the RyR involves the
withdrawal of electrons from a site within the RyR, and that
the closing down of the CRC may involve an increase in the
electron density within this critical region.
The methods developed in this paper to assay for the elec-
tron donor versus acceptor properties of various CRC modu-
lators are similar to those used in previous studies in which
reagents that modify Na+ and Ca2+ channels were examined
(17, 20), and to a recent study in which ryanodine was shown
to act as an electron acceptor using flash photolysis tech-
niques (18). However, this is the first time these types of as-
says have been carried out in an aerobic environment. By in-
cluding a final electron acceptor, such as NBD-Cl or XTT, we
were able to monitor superoxide generated in this light depen-
dent reaction. CRC activators tested (caffeine, doxorubicin,
mitoxanthrone, cystine, GSSG, and diamide) decreased su-
peroxide concentrations, indicating their action as electron
acceptors. However, CRC inhibitors tested (tetracaine, pro-
caine, docosahexaenoic acid, GSH, and cysteine) increased
MB photobleaching, which demonstrated their electron donor
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activity. Cystine, GSSG, and diamide are known to oxidize
sulfhydryl groups, while GSH and cysteine reduce disulfides.
As expected, thiol oxidizing reagents were electron acceptors,
and the reducing agents tested were electron donors. Doxoru-
bicin and mitoxanthrone, both anthraquinones, which had
been proposed to stimulate the Ca2+ release mechanism by
oxidation of critical thiols, are both observed to act as weak
electron acceptors at comparable concentrations to those used
in transport assays (1). Doxorubicin has been shown to acti-
vate the SR CRC by sensitizing the release channel to activa-
tion at low Ca2+ concentrations in a manner similar to caf-
feine. In Fig. 2, it is shown that caffeine at millimolar
concentrations also acts a weak electron acceptor.
The chemical diversity of compounds that activate or in-
hibit the Ca2+ release mechanism is quite striking. We propose
here, for the first time, a common mechanism by which these
compounds appear to modify channel function. Their binding
sites on the ryanodine receptor may be distinct and different,
but common to many activators is their electron acceptor
property, and common to many channel inhibitors tested is
their ability to donate electrons. Implicit to this observation is
that the RyR must also contain a mechanism for funneling
electrons from distinct binding sites to a common site or sites
in which channel function is controlled. The ability of pro-
teins to transfer electrons from a donor to an acceptor sepa-
rated by tens of angstroms is well documented (35). When
thiol reducing agents such as GSH or cysteine are added, pro-
tein disulfides are reduced to thiols and inhibition of the CRC
occurs (43). Conversely, when thiol oxidizing reagents, such
as GSSG, cystine, or diamide are added, the CRC is activated
and thiols are oxidized to disulfides (43). The thiol/disulfide
balance is changed when thiol reducing or oxidizing reagents
are added. However, the decrease in CRC activity induced by
addition of tetracaine (an electron donor) can be reversed by
perfusion of the buffer in contact with the channel (42). It
seems likely that when tetracaine or other non-thiol channel
inhibitors reversibly interact with the ryanodine receptor they
form a charge transfer complex (3) which results in a tran-
sient redistribution of the local electron density within the
RyR. This can be considered an example of a “weak redox in-
teraction”. When the solution is changed and the tetracaine is
removed from the receptor, the electron density redistributes
back to the state before the addition of tetracaine, and hence
the effect of tetracaine is reversed. If the CRC opens and
closes by shifting the local redox environment between more
oxidized and reduced states, then one might expect that chan-
nel activators, such as caffeine, and channel inhibitors, such
as tetracaine, would compete with each other, attempting to
oxidize or reduce common redox active thiol pairs. Because
of the large structural differences between tetracaine and caf-
feine, it is unlikely that they bind to the same site(s) on the
RyR. However, they appear to share a common site of action
(Fig. 7). The data presented suggest that caffeine reverses the
inhibitory effect of the electron donor tetracaine by with-
drawing electrons from a common site of action.
The effects of caffeine and tetracaine on the rate of CPM
fluorescence development also indicate a competitive interac-
tion. Millimolar concentrations of caffeine slow down the
rate at which CPM interacts with hyperreactive thiols associ-
ated with RyR1, while low micromolar concentrations of
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tetracaine, in the presence of caffeine enhances the rate at
which CPM interacts.
This competitive model is further supported by the data
presented in Fig. 9, in which it is observed that tetracaine
shifts the redox potential of hyperreactive thiols to more pos-
itive values, and significantly increases the number of CPM-
labeled thiols on the RyR1. In contrast, caffeine shifts the
redox potential to more negative values and decreases the
number of reactive thiols. Given the large change in the num-
ber of reactive thiols upon addition of caffeine and tetracaine,
and the corresponding changes in the redox potential of these
reactive thiols, it appears as if changes in SH/S-S balance are
caused by oxidation/reduction reactions. Some of these
changes may also be due to conformational changes resulting
from the opening/closing of the CRC. Not only does tetra-
caine donate electrons to dye cation radicals, as shown in Fig.
5, but it also donates electrons to hyperreactive thiols on the
RyR1, favoring the reduced state of the receptor. In a similar
manner, caffeine accepts electrons from dye anion radicals
(Fig. 2), and accepts electrons from RyR1, which favors the
oxidized state of these reactive thiols.
In order for a channel modulator to affect function of a tar-
get protein, it must first bind to, then exchange electrons with
the target protein. It is somewhat surprising how good of a
correlation exists between the ability to donate or accept elec-
trons in model photochemical reactions, and the ability to
modulate channel activity. Electron acceptor activity was
clearly evident with caffeine at 1–2 mM (Fig. 2), with dox-
orubicin and mitoxanthrone at 10–40 M (Fig. 3), while elec-
tron donor activity was observed with DHA at 400 M
(Fig. 5), and the local anesthetics tetracaine and procaine at
~50 M. The similarity between the concentrations of these
channel modulators that affect function and the concentra-
tions that display electron donor/acceptor properties in the as-
says carried out with the excited dye radicals is quite evident.
It appears as if the primary factor that determines the effec-
tiveness of these drugs in modulating function is not deter-
mined only by the binding affinity, but more by the ability of
these drugs to exchange electrons with the RyR protein. Con-
versely, a reagent can be an excellent electron acceptor or
donor. However, if it does not bind to the RyR, it clearly will
not affect channel activity.
Thiol oxidizing reagents such as H2O2, and HOCl, activate
the RyR at low concentrations and inactivate the RyR at high
concentrations (8, 9). This biphasic action on ryanodine bind-
ing and channel activity can only be reversed by the addition
of a thiol reducing agent. The inactivation observed at high
concentrations of oxidizing reagents has been ascribed to the
oxidation of less reactive thiols (5, 32). In a similar manner,
many non-thiol channel activators, including Ca2+ and ryan-
odine show a biphasic concentration dependence. At micro-
molar concentrations, Ca2+ activates the RyR, while at mil-
limolar concentrations, Ca2+ inhibits the CRC in a manner
similar to thiol oxidizing reagents. It is tempting to speculate
that high concentrations of Ca2+ or other channel activators,
over-oxidize RyR thiols, and as a result close down the CRC.
In contrast to reagents that chemically oxidize thiols, the
non-thiol reagents at low and moderate concentrations mod-
ify the release channel in a reversible manner. In this paper,
we postulate that non-thiol channel modulators form a charge
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transfer complex, and we demonstrate that they shift the
SH/S-S balance of reactive thiols on the CRC. While thiol
reagents chemically react with the RyR thiols producing a
long-lasting effect, non-thiol channel modulators shift the
SH/S-S balance in a reversible manner—their effects last
only as long as they remain bound to the RyR.
It is important to note that the proposed mechanism in
which RyR activators are electron acceptors, and channel
inhibitors are electron donors is not unique to the Ca2+ release
channel from SR. Inhibitors of the L-type Ca2+ channel
(nifedipine, verapamil, and diltiazem) have been shown to act
as electron donors, while L-type channel activators such as
Bay K 8644 acts as an electron acceptor (20). Local anesthet-
ics, antiarrhythmics, and some anticonvulsants, which inhibit
sodium channels, acted as electron donors in reactions with
free radicals, while the sodium channel “agonists”: veratri-
dine, N-bromosuccinimide, and chloramine-T all behaved as
electron acceptors, despite differences in chemical structures
(17). It appears as if regulation of channel function by elec-
tron donors and acceptors is a common feature of other trans-
port proteins. A promising approach in the design of new
channel regulators is to either provide new drugs with elec-
tron donor/acceptor properties or to alter existing donor/ac-
ceptor properties by appropriate chemical modifications.
The mechanism by which the regulating action is trans-
ferred from the binding site of the modulator to the channel
gating is not clear. Interactions over long distances are com-
mon to many biological enzymes. In the case of the RyR, the
binding sites associated with Imperatoxin A, calmodulin, and
the FK506 binding protein are all on the cytoplasmic region
of the RyR1, far from the transmembrane portion of the channel
(~11 nm) (26). In spite of the large distance between these
sites, and the pore of the CRC, no conformational changes have
been resolved at the spatial resolution available. In contrast, the
conformation of the cardiac receptor, RyR2, differs consider-
ably when it is depleted of FKBP12.6 in both the transmem-
brane and in the clamp structure region (30). An alternative to a
conformational model for these interactions over relatively long
distances is a model in which electrons are exchanged over
large distances. The binding of a channel activator or inhibitor
results in the formation of a charge transfer complex, and in a
shift of the electron density, which propagates from the binding
site to the regulatory center, where the SH/S-S balance is altered.
This is likely to result in conformational changes with subse-
quent changes in channel gating. This model does not preclude
conformational changes at intermediate steps in this process.
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ABBREVIATIONS
CPM, 7-diethylamino-3-(4’-maleimidylphenyl)-4-methyl-
coumarin; CRC, calcium release channel; DHA, docosa-
hexaenoic acid; DHPR, dihydropyridine receptor; GSH,
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reduced glutathione; GSSG, oxidized glutathione; HSR,
heavy sarcoplasmic reticulum; NBD-Cl , 4-chloro-7-ni-
trobenzo-2-oxa-1,3-diazole; RyR1, ryanodine receptor type 1
from skeletal muscle; RyR2, ryanodine receptor type 2 from
cardiac muscle; SR, sarcoplasmic reticulum; XTT, (2,3-bis(2-
methoxy-4-nitro-5-sulphophenyl)-5-[(phenylamino)car-
bonyl]-2H-tetrazolium hydroxide.
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